Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer
Johan Vansteenkiste, Eric Van Cutsem, Herlinde Dumez, Cong Chen, Justin L. Ricker, Sophia S. Randolph, Patrick SchöffskiVolume:
26
Language:
english
Pages:
6
DOI:
10.1007/s10637-008-9131-6
Date:
October, 2008
File:
PDF, 110 KB
english, 2008